BABA vs RGS

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

RGS exhibits classic 'value trap' characteristics, anchored by a weak Piotroski F-Score of 3/9 and severe liquidity distress. While the current price is significantly below the Graham Number ($276.49), this discrepancy is likely due to impaired assets or an unsustainable capital structure, as evidenced by a Current Ratio of 0.53 and a Quick Ratio of 0.28. The anomalous P/E of 0.60 contrasted with a negative Forward P/E of -10.23 suggests a one-time gain masking a collapse in operational earnings. Despite strong top-line revenue growth, the company's financial health is critical, and technical trends remain entirely bearish.